Rapid Micro Biosystems (RPID) Operating Leases (2022 - 2026)

Rapid Micro Biosystems has disclosed Operating Leases across 5 years of filings, most recently posting $3.3 million for Q1 2026.

• Operating Leases for Q1 2026 came in at $3.3 million, down 28.1% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.3 million (down 28.1% YoY), and the FY2025 annual result was $3.7 million, down 25.84% from the prior year.
• Operating Leases came in at $3.3 million for Q1 2026 at Rapid Micro Biosystems, down from $3.7 million in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $7.7 million in Q2 2022 to a low of $1.3 million in Q1 2022.
• The 5-year median for Operating Leases is $5.6 million (2024), against an average of $5.4 million.
• Across the five-year window, Operating Leases soared 433.85% in 2023 and fell 28.1% in 2026, its largest moves.
• Rapid Micro Biosystems' Operating Leases stood at $7.2 million in 2022, then decreased by 13.72% to $6.2 million in 2023, then declined by 20.28% to $5.0 million in 2024, then slipped by 25.84% to $3.7 million in 2025, then retreated by 9.17% to $3.3 million in 2026.
• The last three Operating Leases figures came in at $3.3 million (Q1 2026), $3.7 million (Q4 2025), and $4.0 million (Q3 2025), per Business Quant data.